A Follow up Study of Patients Treated With Imlifidase Prior to Kidney Transplantation

NCT03611621 · clinicaltrials.gov ↗

COMPLETED

Status

31

Enrollment

INDUSTRY

Sponsor class

Conditions

Kidney Transplant Failure and Rejection

Interventions

DRUG: Imlifidase

Sponsor

Hansa Biopharma AB